US 11365230
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
granted A61KA61K31/675A61K39/0011
Quick answer
US patent 11365230 (Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof) held by IMMUNE DESIGN CORP. expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IMMUNE DESIGN CORP.
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/675, A61K39/0011, A61K39/12, A61P